Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12569517 | Method for treating osteoarthritis with mesenchymal stem cell exosomes | 🖼🧊📄§ | 2026-03-10 | 2040-02-07 | 0 | 31 |
| 12569514 | Stable, highly pure L-cysteine compositions for injection and methods of use | 🖼🧊📄§ | 2026-03-10 | 2045-01-06 | 0 | 31 |
| 12569511 | Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-01 | 0 | 31 |
| 12569504 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | 🖼🧊📄§ | 2026-03-10 | 2045-05-13 | 0 | 31 |
| 12569505 | Oral solid dosage forms comprising cannabinoids | 🖼🧊📄§ | 2026-03-10 | 2045-05-16 | 0 | 31 |
| 12569507 | CAR T-cells for the treatment of bone metastatic cancer | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12569510 | Antiviral prodrugs and pharmaceutical compositions thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-11 | 0 | 31 |
| 12569502 | Use of bile acids and derivatives thereof in preparation of GPR39 agonist | 🖼🧊📄§ | 2026-03-10 | 2040-10-30 | 0 | 31 |
| 12569499 | Intravenous formulations of RK-33 | 🖼🧊📄§ | 2026-03-10 | 2042-08-29 | 0 | 31 |
| 12569503 | Methods and compositions for substituted axially-chiral cannabinol analogs | 🖼🧊📄§ | 2026-03-10 | 2040-03-04 | 0 | 31 |
| 12569500 | Combination comprising tricycle compound and use thereof in preparation of medicament for treating HBV | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12569496 | Treatment of cancer with a RAF inhibitor | 🖼🧊📄§ | 2026-03-10 | 2044-01-26 | 0 | 31 |
| 12569501 | Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions | 🖼🧊📄§ | 2026-03-10 | 2042-10-13 | 0 | 31 |
| 12569492 | Immuno-therapeutic chemical compositions and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2045-07-24 | 0 | 31 |
| 12569494 | Compositions and methods to promote thymic regeneration | 🖼🧊📄§ | 2026-03-10 | 2039-01-11 | 0 | 31 |
| 12569489 | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase | 🖼🧊📄§ | 2026-03-10 | 2044-04-05 | 0 | 31 |
| 12569488 | Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients | 🖼🧊📄§ | 2026-03-10 | 2043-03-03 | 0 | 31 |
| 12569490 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-10 | 2045-01-31 | 0 | 31 |
| 12569483 | Methods for objective assessment of memory, early detection of risk for Alzheimer's disease, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs | 🖼🧊📄§ | 2026-03-10 | 2040-05-22 | 0 | 31 |
| 12569480 | Methods of treating fibrosis using compounds that promote glucose oxidation | 🖼🧊📄§ | 2026-03-10 | 2040-05-27 | 0 | 31 |
| 12569479 | Bupropion as a modulator of drug activity | 🖼🧊📄§ | 2026-03-10 | 2044-04-15 | 0 | 31 |
| 12569486 | Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | 🖼🧊📄§ | 2026-03-10 | 2044-02-13 | 0 | 31 |
| 12569475 | Method for eradicating helicobacter pylori infection in patients regardless of body mass index | 🖼🧊📄§ | 2026-03-10 | 2043-12-07 | 0 | 31 |
| 12569476 | Piperidine urea derivatives for use as inotropic agents | 🖼🧊📄§ | 2026-03-10 | 2045-02-21 | 0 | 31 |
| 12569473 | Methods to treat respiratory infection utilizing castanospermine analogs | 🖼🧊📄§ | 2026-03-10 | 2043-07-05 | 0 | 31 |
| 12569471 | Method of treatment of CNS disorders | 🖼🧊📄§ | 2026-03-10 | 2043-07-17 | 0 | 31 |
| 12569469 | Pharmaceutical composition for oral administration of edaravone and method of administering same | 🖼🧊📄§ | 2026-03-10 | 2045-05-13 | 0 | 31 |
| 12569468 | Use of palovarotene in treatment against HBV virus | 🖼🧊📄§ | 2026-03-10 | 2041-06-01 | 0 | 31 |
| 12569463 | Method for treating diabetes | 🖼🧊📄§ | 2026-03-10 | 2042-09-22 | 0 | 31 |
| 12569459 | Compositions and methods for treating pulmonary edema or lung inflammation | 🖼🧊📄§ | 2026-03-10 | 2041-03-26 | 0 | 31 |
| 12569456 | Methods for the treatment of cysteamine sensitive disorders | 🖼🧊📄§ | 2026-03-10 | 2043-10-13 | 0 | 31 |
| 12569472 | PPARγ agonists for treatment of kidney disease | 🖼🧊📄§ | 2026-03-10 | 2041-04-27 | 0 | 31 |
| 12569455 | Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome | 🖼🧊📄§ | 2026-03-10 | 2041-02-05 | 0 | 31 |
| 12569447 | System and method for additive manufacturing using an omnidirectional magnetic movement apparatus | 🖼🧊📄§ | 2026-03-10 | 2044-04-26 | 0 | 31 |
| 12569448 | Membrane-based two component therapeutic gas release system for oral administration | 🖼🧊📄§ | 2026-03-10 | 2040-10-13 | 0 | 31 |
| 12569446 | Enteral sustained-release sugar alcohol additive and preparation method and application thereof | 🖼🧊📄§ | 2026-03-10 | 2045-06-04 | 0 | 31 |
| 12569443 | Gastro-retentive drug delivery system | 🖼🧊📄§ | 2026-03-10 | 2042-06-07 | 0 | 31 |
| 12569440 | Solid formulation of a 1,2,4-oxadiazole derivative | 🖼🧊📄§ | 2026-03-10 | 2040-07-17 | 0 | 31 |
| 12569436 | Self-regulating photo-curable cooling hydrogel and preparation method and application thereof | 🖼🧊📄§ | 2026-03-10 | 2045-09-02 | 0 | 31 |
| 12569437 | Disease-site-specific liposomal formulation | 🖼🧊📄§ | 2026-03-10 | 2043-10-23 | 0 | 31 |
| 12569404 | Methods, systems, and materials for making unit dosage forms | 🖼🧊📄§ | 2026-03-10 | 2043-01-24 | 0 | 31 |
| 12569414 | Sunscreen compositions containing porous metal oxide spheres | 🖼🧊📄§ | 2026-03-10 | 2040-03-12 | 0 | 31 |
| 12569413 | Multifunctional facial patch product | 🖼🧊📄§ | 2026-03-10 | 2043-10-04 | 0 | 31 |
| 12569425 | Aerosol hair care product | 🖼🧊📄§ | 2026-03-10 | 2041-07-15 | 0 | 31 |
| 12569426 | Topical skin preparation composition | 🖼🧊📄§ | 2026-03-10 | 2041-03-22 | 0 | 31 |
| 12569433 | Microemulsion delivery systems for water-based beverages | 🖼🧊📄§ | 2026-03-10 | 2042-02-16 | 0 | 31 |
| 12569429 | Skin penetration enhancer for royal jelly | 🖼🧊📄§ | 2026-03-10 | 2043-10-26 | 0 | 31 |
| 12569049 | Deformable absorbent substrate for a packaging and/or application assembly for a cosmetic product | 🖼🧊📄§ | 2026-03-10 | 2039-06-20 | 0 | 31 |
| 12570707 | Codon-optimised complement factor I | 🖼🧊📄§ | 2026-03-10 | 2039-12-20 | 0 | 31 |
| 12570958 | Single- and multi-chain chimeric antigen receptors | 🖼🧊📄§ | 2026-03-10 | 2038-12-19 | 0 | 31 |